References
- Abend J.R., Low J.A., Imperiale M.J.: Inhibitory effect of gamma interferon on BK virus gene expression and replication. J Virol 2007, 81, 272–279, doi: 10.1128/JVI.01571-06.
- Alhaji N.B., Amin J., Aliyu M.B., Mohammad B., Babalobi O.O., Wungak Y., Odetokun, I.A.: Economic impact assessment of foot-and-mouth disease burden and control in pastoral local dairy cattle production systems in Northern Nigeria: A cross-sectional survey. Prev Vet Med 2020, 177, 104974, doi: 10.1016/j.prevetmed.2020.104974.
- Arzt J., Pacheco J.M., Stenfeldt C., Rodriguez L.L.: Pathogenesis of virulent and attenuated foot-and-mouth disease virus in cattle. Virol J 2017, 14, 89, doi: 10.1186/s12985-017-0758-9.
- Biswal J.K., Ranjan R., Subramaniam S., Mohapatra J.K., Patidar S., Sharma M.K., Bertram M.R., Brito B.P., Rodriguez L.L., Pattnaik B., Arzt J.: Genetic and antigenic variation of foot-and-mouth disease virus during persistent infection in naturally infected cattle and Asian buffalo in India. PLoS ONE 2019, 14, e0214832, doi: 10.1371/journal.pone.0214832.
- Brito B.P., Rodriguez L.L., Hammond J.M., Pinto J., Perez A.M: Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014. Transbound Emerg Dis 2017, 64, 316–332, doi: 10.1111/tbed.12373.
- Cottam E.M., Wadsworth J., Shaw A.E., Rowlands R.J., Goatley L., Maan S., Maan N.S., Mertens P.P., Ebert K., Li Y., Ryan E.D., Juleff N., Ferris N.P., Wilesmith J.W., Haydon D.T., King D.P., Paton D.J., Knowles N.J.: Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007. PLoS Pathog 2008, 4, e1000050, doi.org/10.1371/journal.ppat.1000050.
- Doel T.: Chapter 5: Natural and Vaccine Induced Immunity to FMD. In: Foot-and-Mouth Disease Virus edited by B.W.J. Mahy, Springer Nature, Cham, 2004, pp 103–131, doi: 10.1007/3-54027109-0_5.
- Golde W.T., de los Santos T., Robinson L., Grubman M.J., Sevilla N., Summerfield A., Charleston B.: Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus. Transbound Emerg Dis 2011, 58, 283–290, doi: 10.1111/j.1865-1682.2011.01223.x.
- Grubman M.J., Moraes M.P., Diaz-San Segundo F., Pena L., de los Santos T.: Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol Med Microbiol 2008, 53, 8–17, doi: 10.1111/j.1574-695X.2008.00409.x.
- Haagmans B.L., Osterhaus A.D.M.E.: Chapter 36 – SARS. In: Vaccines for Biodefense and Emerging and Neglected Diseases edited by A.D.T. Barrett, L.R. Stanberry. Academic Press Cambridge, MA, 2009, pp 671–683.
- Janssens S., Beyaert R.: Role of Toll-Like Receptors in Pathogen Recognition. Clin Microbiol Rev 2003, 16, 637–646, doi: 10.1128/CMR.16.4.637-646.2003.
- Kang S., Brown H.M., Hwang S.: Direct Antiviral Mechanisms of Interferon-Gamma. Immune Netw 2018, 18, e3, doi: 10.4110/in.2018.18.e33.
- Kitching R.P.: Chapter 6: Global epidemiology and prospects for control of foot-and-mouth disease. In: Foot-and-Mouth Disease Virus edited by B.W.J. Mahy, Springer Nature, Cham, 2004, pp 133–148, doi.org/10.1007/3-540-27109-0_6.
- Kitching R.P.: Clinical variation in foot and mouth disease: Cattle. Rev Sci Tech Off Int Epiz 2003, 21, 499–504, doi: 10.20506/rst.21.3.1343.
- Knight-Jones T.J.D., Rushton J.: The economic impacts of foot and mouth disease -what are they, how big are they and where do they occur? Prev Vet Med 2013, 112, 161–173, doi: 10.1016/j.prevetmed.2013.07.013.
- Lindell D.M., Lane T.E., Lukacs N.W.: CxCL10/CxCR3-mediated Responses Promote Immunity to Respiratory Syncytial Virus Infection by Augmenting Dendritic Cell and CD8+ T Cell Efficacy. Eur J Immunol 2008, 38, 2168–2179, doi.org/10.1002/eji.200838155.
- Longjam N., Tayo T.: Antigenic variation of Foot and Mouth Disease Virus – An Overview. Vet World 2011, 4, 475–479, doi: 10.5455/vetworld.2011.475-479.
- Mahapatra M., Yuvaraj S., Madhanmohan M., Subramaniam S., Pattnaik B., Paton D.J., Srinivasan V.A., Parida S.: Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses. Vaccine 2015, 33, 693–700, doi: 10.1016/j.vaccine.2014.11.058.
- Pacheco J.M., Smoliga G.R., O’Donnell V., Brito B.P., Stenfeldt C., Rodriguez L.L., Arzt J.: Persistent Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Cattle; Tissue-Specific Distribution and Local Cytokine Expression. PLoS One, 2015, 10, e0125698, doi: 10.1371/journal.pone.0125698.
- Park J., Takeuchi A., Sharma S.: Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc. J Biol Chem 1996, 271, 20914–20921, doi: 10.1074/jbc.271.34.20914.
- Paton D.J., Gubbins S., King D.P.: Understanding the transmission of foot-and-mouth disease virus at different scales. Curr Opin Virol 2018, 28, 85–91, doi: 10.1016/j.coviro.2017.11.013
- Perry B.D., Rich K.M.: Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control. Vet Rec 2007, 160, 238–241, doi: 10.1136/vr.160.7.238.
- Rao X., Huang X., Zhou Z., Lin X.: An improvement of the 2ˆ (delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 2013, 3, 71–85.
- Razvi E.S., Welsh R.M.: Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol 1993, 67, 5754–5765, doi: 10.1128/JVI.67.10.5754-5765.1993.
- Stenfeldt C., Heegaard P.M., Stockmarr A., Belsham G.J.: Modulation of cytokine mRNA expression in pharyngeal epithelial samples obtained from cattle infected with foot-and-mouth disease virus. J Comp Pathol 2012, 146, 243–252, doi: 10.1016/j.jcpa.2011.06.005.
- Schroder K., Hertzog P.J., RavasiT., Hume D.A.: Interferon-ɣ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75, 163–189, doi: 10.1189/jlb.0603252.
- Takeda K., Akira S.: Toll-like receptors. Curr Protoc Immunol 2015, 109, 14.12.1–14.12.10, doi: 10.1002/0471142735.im1412s109.
- Thorley-Lawson D.A., Schooley R.T., Bhan A.K., Nadler L.M.: Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 1982, 30, 415–425, doi: 10.1016/0092-8674(82)90239-2.
- Tissot C., Rebouissou C., Klein B., Mechti N.: Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules. J Interferon Cytokine Res 1997, 17, 17–26, doi: 10.1089/jir.1997.17.17.
- World Organisation for Animal Health (OIE): Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th Edition. Paris, 2004, pp 15–17.
- Van Wyk B., Snider M., Scruten E., van Drunen Littel-van den Hurk S., Scott Napper S.: Induction of functional interferon alpha and gamma responses during acute infection of cattle with non-cytopathic bovine viral diarrhea virus. Vet Microbiol, 2016, 195, 104–114, doi: 10.1016/j.vetmic.2016.09.015.
- Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin J.J., Thorley-Lawson D.A.: Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol 1991,146, 2192–2200.
- Zhang Z., Doel C., Bashiruddin J.B.: Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle. Vet Res 2015, 46, 132, doi: 10.1186/s13567-015-0276-y.